0001213900-22-027023 | 10-Q | XBRL Viewer

Document And Entity Information - shares	3 Months Ended
Document And Entity Information - shares	Mar. 31, 2022	May 16, 2022
Document Information Line Items
Entity Registrant Name	LogicMark, Inc.
Trading Symbol	LGMK
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		9,593,378
Amendment Flag	false
Entity Central Index Key	0001566826
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Mar. 31, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-36616
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	46-0678374
Entity Address, Address Line One	2801 Diode Lane
Entity Address, City or Town	Louisville
Entity Address, State or Province	KY
Entity Address, Postal Zip Code	40299
City Area Code	(502)
Local Phone Number	442-7911
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current Assets
Cash	$ 12,224,887	$ 12,044,415
Restricted cash	210,118	210,131
Accounts receivable, net	133,262	98,749
Inventory, net	876,084	1,237,280
Prepaid expenses and other current assets	893,388	849,190
Total Current Assets	14,337,739	14,439,765
Property and equipment:
Equipment	404,925	410,444
Furniture and fixtures	78,268	35,761
Tooling and molds	9,427	9,427
Property and equipment, gross	492,620	455,632
Accumulated depreciation	(455,889)	(455,632)
Property and equipment, net	36,731	0
Right-of-use assets	232,569	248,309
Goodwill	10,958,662	10,958,662
Other intangible assets, net of amortization of $4,322,026 and $4,127,920, respectively	4,282,541	4,476,647
Total Assets	29,848,242	30,123,383
Current Liabilities
Accounts payable	1,059,414	492,431
Accrued expenses	766,313	849,285
Total Current Liabilities	1,825,727	1,341,716
Other long-term liabilities	367,387	385,196
Total Liabilities	2,193,114	1,726,912
Commitments and Contingencies (Note 8)
Series C Preferred Stock
Series C Preferred Stock, par value $0.0001 per share: 2,000 shares designated; 200 shares issued and outstanding as of March 31, 2022, and December 31, 2021	1,807,300	1,807,300
Stockholders’ Equity
Preferred Stock, par value $0.0001 per share: 10,000,000 shares authorized
Series F Preferred Stock, par value $0.0001 per share: 1,333,333 shares designated; 173,333 shares issued and outstanding as of March 31, 2022, aggregate liquidation preference of $520,000 as of March 31, 2022, and December 31, 2021	520,000	520,000
Common Stock, par value $0.0001 per share: 100,000,000 shares authorized; 9,593,378 and 9,163,039 issued and outstanding as of March 31, 2022, and December 31, 2021	959	917
Additional paid-in capital	105,279,875	104,725,115
Accumulated deficit	(79,953,006)	(78,656,861)
Total Stockholders’ Equity	25,847,828	26,589,171
Total Liabilities, Series C Preferred Stock and Stockholders’ Equity	$ 29,848,242	$ 30,123,383

Condensed Statements of Operations (Unaudited) - USD ($)

3 Months Ended

Mar. 31, 2022

Mar. 31, 2021

^[1]

Income Statement [Abstract]

Revenues

$ 3,650,689

$ 2,438,682

Costs of goods sold

1,447,305

989,388

Gross Profit

2,203,384

1,449,294

Operating Expenses

Direct operating cost

474,442

244,669

Selling and marketing

189,207

80,123

Research and development

262,484

313,896

General and administrative

2,335,949

1,379,071

Other expense

30,084

10,568

Depreciation and amortization

194,363

203,857

Total Operating Expenses

3,486,529

2,232,184

Operating Loss

(1,283,145)

(782,890)

Other Income and (Expense)

Interest expense

(861,248)

Forgiveness of Paycheck Protection Program loan and accrued interest

303,710

Warrant modification expense

(2,881,729)

Total Other Expense, Net

(3,439,267)

Loss before Income Taxes

(1,283,145)

(4,222,157)

Income Tax (Expense) Benefit

Net Loss

(1,283,145)

(4,222,157)

Preferred stock dividends

(88,000)

(1,555,801)

Net Loss Applicable to Common Stockholders

$ (1,371,145)

$ (5,777,958)

Net Loss Per Share - Basic and Diluted (in Dollars per share)

$ (0.14)

$ (1.2)

Weighted Average Number of Common Shares Outstanding - Basic and Diluted (in Shares)

9,481,963

4,819,255

[1]	Expenses in 2021 have been reclassified to conform to the 2022 presentation format.

Condensed Changes in Stockholders’ Equity (Unaudited) - USD ($)

Preferred Stock

Common Stock

Additional Paid-in Capital

Accumulated Deficit

Total

Balance at Dec. 31, 2020

$ 407

$ 74,586,801

$ (65,427,997)

$ 9,159,211

Balance (in Shares) at Dec. 31, 2020

4,061,997

Issuance of stock options for services

40,000

Issuance of Series E preferred stock, net

$ 4,000,003

4,000,003

Issuance of Series E preferred stock, net (in Shares)

1,476,016

Conversion of Series E preferred stock to common stock

$ (4,000,003)

$ 29

3,999,974

Conversion of Series E preferred stock to common stock (in Shares)

(1,476,016)

295,203

Deemed dividend related to beneficial conversion feature of Series E preferred stock

1,480,801

(1,480,801)

Exercise of common stock purchase warrants on a cash

$ 54

6,669,957

6,670,011

Exercise of common stock purchase warrants on a cash (in Shares)

536,774

Exercise of common stock purchase warrants on a cashless basis

$ 42

(42)

Exercise of common stock purchase warrants on a cashless basis (in Shares)

423,933

Warrant modification expense recorded in connection with the issuance of replacement warrants

2,881,729

Shares issued in connection with the management incentive plan for 2018 and 2019

$ 1

80,455

80,456

Shares issued in connection with the management incentive plan for 2018 and 2019 (in Shares)

13,283

Fees incurred in connection with equity offerings

(44,156)

Series C Preferred stock dividends

(75,000)

Net loss

(4,222,157)

^[1]

Balance at Mar. 31, 2021

$ 533

89,620,519

(71,130,955)

18,490,097

Balance (in Shares) at Mar. 31, 2021

5,331,190

Balance at Dec. 31, 2021

$ 520,000

$ 917

104,725,115

(78,656,861)

26,589,171

Balance (in Shares) at Dec. 31, 2021

173,333

9,163,039

Issuance of stock options for services

385,339

Shares issued as stock compensation

$ 42

244,421

244,463

Shares issued as stock compensation (in Shares)

430,339

Series C Preferred stock dividends

(75,000)

Series F Preferred stock dividends

(13,000)

Net loss

(1,283,145)

Balance at Mar. 31, 2022

$ 520,000

$ 959

$ 105,279,875

$ 79,953,006

$ 25,847,828

Balance (in Shares) at Mar. 31, 2022

173,333

9,593,378

[1]	Expenses in 2021 have been reclassified to conform to the 2022 presentation format.

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash Flows from Operating Activities
Net loss	$ (1,283,145)	$ (4,222,157)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	257	16,012
Stock based compensation	629,802	40,000
Amortization of debt discount		77,800
Amortization of intangible assets	194,106	187,845
Amortization of deferred debt issuance costs		402,454
Non-cash charge for modification of warrant terms		2,881,729
Forgiveness of Paycheck Protection Plan loans and accrued interest		(303,710)
Changes in operating assets and liabilities:
Accounts receivable	(34,513)	66,045
Inventory	361,196	(13,128)
Prepaid expenses and other current assets	(44,198)	(80,715)
Accounts payable	566,983	(518,601)
Accrued expenses	(98,041)	463,660
Total Adjustments	1,575,592	3,219,391
Net Cash Provided by (Used in) Operating Activities	292,447	(1,002,766)
Cash flows from Investing Activities
Purchase of Equipment	(36,988)
Net Cash Used by Investing Activities	(36,988)
Cash flows from Financing Activities
Proceeds from sale of common stock and warrants		6,670,494
Proceeds received in connection with issuance of Series E preferred stock, net		4,000,003
Term loan repayment		(5,515,625)
Fees paid in connection with equity offerings		(23,698)
Preferred Stock Dividends	(75,000)
Net Cash (Used in) Provided by Financing Activities	(75,000)	5,131,174
Net Increase in Cash and Restricted Cash	180,459	4,128,408
Cash and Restricted Cash - Beginning of Year	12,254,546	4,537,546
Cash and Restricted Cash - End of Period	12,435,005	8,665,954
Cash paid during the periods for:
Interest		443,975
Taxes		25,999
Non-cash investing and financing activities:
Accrued fees incurred in connection with equity offerings		20,458
Accrued preferred stock dividends	107,933	75,000
Common stock issued in connection with management incentive plans		80,456
Conversion of Series E preferred stock to common stock		$ 4,000,003

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 4 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

The preparation of financial statements in conformity with generally accepted accounting principles in the United States (U.S. GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s management evaluates these significant estimates and assumptions, including those related to the fair value of acquired assets and liabilities, stock-based compensation, income taxes, allowance for doubtful accounts, long-lived assets, and inventories, and other matters that affect the financial statements and disclosures. Actual results could differ from those estimates.

CASH

The Company considers all highly liquid securities with an original maturity date of three months or less when purchased to be cash equivalents. Due to their short-term nature, cash equivalents are carried at cost, which approximates fair value. On March 31, 2022, and December 31, 2021, the Company had no cash equivalents, respectively.

RESTRICTED CASH

On March 31, 2022, and December 31, 2021, the Company had restricted cash of $210,118 and $210,131, respectively. Restricted cash includes amounts held back by the Company’s third-party credit card processor for potential customer refunds, claims, and disputes and held as collateral for company credit cards.

CONCENTRATIONS OF CREDIT RISK

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company maintains its cash balances in large well-established financial institutions located in the United States. At times, the Company’s cash balances may be uninsured or in deposit accounts that exceed the Federal Deposit Insurance Corporation (FDIC) insurance limits.

REVENUE RECOGNITION

The Company’s revenues consist of product sales to either end customers or distributors. The Company’s revenues are derived from contracts with customers, which are in most cases customer purchase orders. For each contract, the promise to transfer the control of the products, each of which is individually distinct, is considered to be the identified performance obligation. As part of the consideration promised in each contract, the Company evaluates the customer’s credit risk. Our contracts do not have any financing components, as payment terms are generally due Net-30 days after the invoice date. The Company’s products are almost always sold at fixed prices. In determining the transaction price, we evaluate whether the price is subject to any refunds, due to product returns or adjustments due to volume discounts, rebates, or price concessions to determine the net consideration we expect to be entitled to. The Company’s sales are recognized at a point-in-time under the core principle of recognizing revenue when control transfers to the customer, which generally occurs when the Company ships or delivers the product from its fulfillment center to our customers, when our customer accepts and has the legal title of the goods, and the Company has a present right to payment for such goods. Based on the respective contract terms, most of our contract revenues are recognized either (i) upon shipment based on free on board (FOB) shipping point, or (ii) when the product arrives at its destination. For the three months ended March 31, 2022, and 2021, none of our sales were recognized over time.

SALES TO DISTRIBUTORS AND RESELLERS

Sales to certain distributors and resellers are made under terms allowing limited rights of return of the Company’s products held in their inventory or upon sale to their end customers. The Company maintains a reserve for unprocessed and estimated future price adjustments claims and returns as a refund liability. The reserve is recorded as a reduction to revenue in the same period that the related revenue is recorded and is calculated based on an analysis of historical claims and returns over a period of time to appropriately account for current pricing and business trends. Similarly, sales returns and allowances are recorded based on historical return rates, as a reduction in revenue with a corresponding reduction to cost of sales for the estimated cost of inventory that is expected to be returned. These reserves were not material upon the adoption of Topic 606 on January 1, 2018, nor were they material on the Condensed Balance Sheets on March 31, 2022, and December 31, 2021.

SHIPPING AND HANDLING

Amounts billed to customers for shipping and handling are included in revenues. The related freight charges incurred by the Company are included in the cost of goods sold, and were $191,662 and $106,425, respectively, for the three months ended March 31, 2022, and 2021.

ACCOUNTS RECEIVABLE

For the three months ended March 31, 2022, and 2021, the Company’s revenues primarily included shipments of the LogicMark products. The terms and conditions of these sales provided certain customers with trade credit terms. In addition, these sales were made to the retailers with no rights of return and are subject to the normal warranties offered to the ultimate consumer for product defects.

Accounts receivable are stated at net realizable value. The Company regularly reviews accounts receivable balances and adjusts the receivable reserves as necessary whenever events or circumstances indicate the carrying value may not be recoverable. On March 31, 2022, and December 31, 2021, the Company had an allowance for doubtful accounts of $7,014 and $5,411, respectively.

INVENTORY

The Company measures inventory at the lower of cost or net realizable value, defined as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation.

The Company performs regular reviews of inventory quantities on hand and evaluates the realizable value of its inventories. The Company adjusts the carrying value of the inventory as necessary with estimated valuation reserves for excess, obsolete, and slow-moving inventory by comparing the individual inventory parts to forecasted product demand or production requirements. The inventory is valued at the lower of cost or net realizable value with cost determined using the first-in, first-out method. As of March 31, 2022, inventory was comprised of $876,084 in finished goods on hand. As of December 31, 2021, inventory was comprised of $1,237,280 in finished goods on hand. The Company is required to prepay for certain inventory with certain vendors until credit terms can be established. As of March 31, 2022, and December 31, 2021, $542,931 and $559,938 respectively, of prepayments made for inventory are included in prepaid expenses and other current assets on the balance sheet. An allowance for obsolete inventory amounted to $24,868 on March 31,2022 and December 31, 2021.

LONG-LIVED ASSETS

Long-lived assets, such as property and equipment, and other intangibles are evaluated for impairment whenever events or changes in circumstances indicate the carrying value of an asset may not be recoverable. When indicators exist, the Company tests for the impairment of the definite-lived assets based on the undiscounted future cash flow the assets are expected to generate over their remaining useful lives, compared to the carrying value of the assets. If the carrying amount of the assets is determined not to be recoverable, a write-down to fair value is recorded. Management estimates future cash flows using assumptions about expected future operating performance. Management’s estimates of future cash flows may differ from actual cash flow due to, among other things, technological changes, economic conditions, or changes to the Company’s business operations.

PROPERTY AND EQUIPMENT

Property and equipment consisting of equipment, furniture and fixtures, and tooling and molds are stated at cost. The costs of additions and improvements are generally capitalized and expenditures for repairs and maintenance are expensed in the period incurred. When items of property and equipment are sold or retired, the related costs and accumulated depreciation are removed from the accounts, and any gain or loss is included in income. Depreciation of property and equipment is provided utilizing the straight-line method over the estimated useful life of the respective asset as follows:

Equipment	5 years
Furniture and fixtures	3 to 5 years
Tooling and molds	2 to 3 years

GOODWILL

Goodwill is reviewed annually in the fourth quarter, or when circumstances indicate that an impairment may have occurred. The Company first performs a qualitative assessment of goodwill impairment, which considers factors such as market conditions, performance compared to forecast, business outlook, and unusual events. If the qualitative assessment indicates a possible goodwill impairment, goodwill is then quantitatively tested for impairment. The Company may elect to bypass the qualitative assessment and proceed directly to the quantitative test. If a quantitative goodwill impairment test is required, the fair value is determined using a variety of assumptions including estimated future cash flows using applicable discount rates (income approach) and comparisons to other similar companies (market approach).

OTHER INTANGIBLE ASSETS

The Company’s intangible assets are related to the acquisition of LogicMark and are included in other intangible assets in the Company’s balance sheet on March 31, 2022, and December 31, 2021.

On March 31, 2022, Other intangible assets, net of amortization, are comprised of patents of $1,978,016; trademarks of $899,599; and customer relationships of $1,404,926. On December 31, 2021, the other intangible assets are comprised of patents of $2,072,984; trademarks of $915,619; and customer relationships of $1,488,044. The Company amortizes these intangible assets using the straight-line method over their estimated useful lives which for the patents, trademarks, and customer relationships are 11 years, 20 years, and 10 years, respectively. During the three months ended March 31, 2022, and 2021, the Company recorded amortization expense of $194,106 and $187,845, respectively.

As of March 31, 2022, total amortization expense estimated for the remainder of fiscal year 2022 is $567,709, and for each of the next five fiscal years, the total amortization expense is estimated to be as follows: 2023 - $761,815; 2024 - $761,815; 2025 - $761,815; 2026 - $618,790; and 2027- $272,235.

CONVERTIBLE INSTRUMENTS

The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts that feature conversion options. The accounting standards require companies to separate conversion options from their host instruments and account for them as free-standing derivatives according to certain criteria. The criteria include circumstances in which (i) the economic characteristics and risks of the embedded derivative are not closely related to the economic characteristics and risks of the host contract, (ii) the hybrid instrument that embodies both the embedded derivative and the host contract is not re-measured at fair value under generally accepted accounting principles with changes in fair value reported in earnings as they occur and (iii) a separate instrument with the same terms as the embedded derivative would be considered a derivative. The derivative is subsequently marked to market at each reporting date based on the current fair value, with the changes in fair value reported in the results of operations.

Conversion options with variable settlement features such as provisions to adjust the conversion price upon subsequent issuances at exercise prices more favorable than that in the hybrid contract generally result in their separation from the host instrument.

The Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. The debt discounts under these arrangements are amortized over the earlier of (i) the term of the related debt using the straight-line method which approximates the interest rate method or (ii) conversion of the debt. The amortization of debt discount is included as interest expense included in other income and expenses in the statements of operations.

DERIVATIVE FINANCIAL INSTRUMENTS

The Company does not use derivatives to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. Derivative financial instruments accounted for as liabilities are initially recorded at fair value and then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivatives, the Company uses the Black-Scholes or binomial option valuation model to value the derivatives at inception and on subsequent valuation dates. The Company accounts for conversion features that are embedded within the Company’s convertible notes payable that do not have fixed settlement provisions as a separate derivative. In addition, warrants issued by the Company that do not have fixed settlement provisions are also treated as derivatives. The classification of derivatives, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative liabilities are classified in the balance sheet as current or non-current based on whether net-cash settlement of the derivative could be required within 12 months of the balance sheet date.

STOCK-BASED COMPENSATION

The Company accounts for share-based awards exchanged for employee services at the estimated grant date fair value of the award. The Company accounts for equity instruments issued to non-employees at their fair value on the measurement date. The measurement of stock-based compensation is subject to periodic adjustment as the underlying equity instrument vests or becomes non-forfeitable. Stock-based compensation charges are amortized over the vesting period or as earned. Stock-based compensation is recorded in the same component of operating expenses as if it were paid in cash. The Company generally issues new shares of common stock to satisfy conversion and warrant exercises.

NET LOSS PER SHARE

Basic loss per share was computed using the weighted average number of common shares outstanding. Diluted loss per share includes the effect of diluted common stock equivalents. Potentially dilutive securities from the exercise of stock options to purchase 348,284 shares of common stock and warrants to purchase 4,295,380 shares of common stock as of March 31, 2022, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive. Potentially dilutive securities from the exercise of stock options to purchase 36,364 shares of common stock and warrants to purchase 937,813 shares of common stock as of March 31, 2021, were excluded from the computation of diluted net loss per share because the effect of their inclusion would have been anti-dilutive.

RESEARCH AND DEVELOPMENT

Research and development costs are expenditures on new market development and related engineering costs. In addition to internal resources, the Company utilizes functional consulting resources, third-party software, and hardware development firms. The Company expenses all research and development costs as incurred.

RECENT ACCOUNTING PRONOUNCEMENTS

Recent accounting standards that have been issued or proposed by FASB (Financial Accounting Standards Board) or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on the Company’s financial statements upon adoption.

Stockholders' Equity

3 Months Ended

Mar. 31, 2022

Stockholders' Equity Note [Abstract]

STOCKHOLDERS’ EQUITY

NOTE 6 - STOCKHOLDERS’ EQUITY

October 2021 Reverse stock split

On October 15, 2021, the Company announced that its shareholders had approved a reverse split of its common stock and Series C Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Preferred stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders. The number of outstanding common shares was reduced from approximately 88.3 million shares to approximately 8.8 million shares, and the number of outstanding Series C preferred shares was reduced from 2,000 shares to 200 shares. The reverse stock split did not affect the total number of shares of capital stock, including Series C Preferred Stock, that the company is authorized to issue.

Earnings per share and all share data for the three months ended March 31, 2021, have been retroactively adjusted to reflect the reverse stock split in accordance with ASC 260-10-55-12, Restatement of EPS Data.

September 2021 Offering

On September 15, 2021, the Company sold an aggregate of (i) 2,788,750 shares of common stock, par value of $0.0001 per share, and (ii) accompanying warrants to purchase up to an aggregate of 2,788,750 shares of Common Stock, at an exercise price of $4.95 per share, both of which include the underwriter’s full over-allotment option to purchase an additional 363,750 shares of common stock.

The Shares and the Warrants were offered and sold to the public pursuant to the Company’s registration statement on Form S-1, as amended (File No. 333-259105), filed by the Company with the Securities and Exchange Commission (SEC) under the Securities Act of 1933, as amended (Securities Act), which became effective on September 14, 2021.

The Warrants were not immediately exercisable, as the Company did not have a sufficient number of shares of Common Stock to reserve for issuance for the Warrants until the date (the “Initial Exercise Date”) that the Company’s stockholders approved an amendment to the Company’s certificate of incorporation to affect a reverse stock split of the shares of Common Stock so that there were a sufficient number of shares of Common Stock for issuance upon exercise of the Warrants. The Warrants became exercisable on the Initial Exercise Date (the effective date of the reverse stock split) and will terminate five years after the Initial Exercise Date. The exercise price of the Warrants is subject to customary adjustments for stock dividends, stock splits and other subdivisions, combinations, and re-classifications, and was reset on the date of the Company’s reverse stock split to the lower of (i) the closing price per share of the Common Stock immediately before the reverse stock split, giving effect to the reverse stock split and (ii) the exercise price then in effect. The Warrants are also exercisable on a cashless basis under certain circumstances, any time after the Initial Exercise Date, pursuant to the formula outlined in the Warrants. On October 15, 2021, after shareholder and Board approval of the reverse stock split, the exercise price for the Warrants was adjusted to $3.956 per share, The reverse stock split and the exercise price were retroactively reported in accordance with ASC 260-10-55-12, Restatement of EPS Data.

On the Closing Date, the Company received gross proceeds of approximately $12.5 million, before deducting underwriting discounts and commissions and estimated offering expenses. The Company intends to use the net proceeds from the Offering primarily for new product development, marketing, working capital, and liability reduction purposes.

August 2021 Offering

On August 13, 2021, the Company entered into a securities purchase agreement with institutional accredited investors providing for an aggregate investment of $4,000,000 for the issuance by the Company of (i) 1,333,333 shares of Series F Convertible Preferred Stock, par value $0.0001 per share, of the Company (the Series F Preferred Stock) convertible into shares of common stock, par value $0.0001 per share, of the Company that is issuable upon conversion of shares of Series F Preferred Stock; (ii) warrants, with a term of five and a half years exercisable after February 16, 2022, to purchase an aggregate of up to 666,667 shares of Common Stock at an exercise price of $7.80 per share. The securities issued to the investors were exempt from registration under the Securities Act of 1933, as amended, or the Securities Act, in reliance on Section 4(a)(2) thereof and Rule 506 of Regulation D thereunder, based on representations made by the investors, their prior relationship with the Company, and the absence of any general solicitation. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In the three months ended September 30, 2021, 1,160,000 shares of Series F preferred stock were converted into 656,604 shares of common stock. On October 15, 2021, after shareholder and Board approval of the reverse stock split, the exercise price for the Warrants was adjusted to $4.95 per share and was retroactively reported in accordance with ASC 260-10-55-12, Restatement of EPS Data.

February 2021 Offering

On February 2, 2021, the Company closed a registered direct offering and concurrent private placement pursuant to which the Company issued (i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.

January 2021 Warrant exchange

On January 8, 2021, the Company entered into a Warrant Amendment and Exercise Agreement (the “Amendment”) with holders (the “Holder”) of a common stock purchase warrant, dated April 4, 2019, previously issued by the Company (the “Original Warrant”).

In consideration for each exercise of the Original Warrant within 45 calendar days of the Amendment, in addition to the issuance of the Warrant shares, the Company agreed to deliver a new warrant to purchase shares of the Company’s common stock equal to the number of Original Warrants that the Holder exercised, at an exercise price of $15.25 per share, which represents the average Nasdaq Official Closing Price of the common stock for the five trading days immediately preceding the date of the Amendment (the “New Warrants”). The Investor held Original Warrants exercisable for up to 246,913 shares of common stock, subsequently exercised 50,000 Original Warrants within the 45 days, and received 50,000 New Warrants in addition to the Warrant shares. The Investor may continue to exercise the Original Warrants after 45 calendar days of the Amendment, but will not receive New Warrants for the exercise.

Series C Preferred Stock

In May 2017, the Company authorized Series C Preferred Stock. Holders of Series C Preferred Stock are entitled to receive dividends of 15% per year, payable in cash. For the three months ended March 31, 2022, and 2021, the Company recorded Series C Preferred Stock dividends of $75,000 in each period.

The Series C Preferred Stock may be redeemed by the Company at the Company’s option in cash at any time, in whole or in part, upon payment of the stated value of the Series C Preferred Stock and unpaid dividends. If a “fundamental change” occurs, the Series C Preferred Stock shall be immediately redeemed in cash equal to the stated value of the Series C Preferred Stock, and unpaid dividends. A fundamental change includes but is not limited to any change in the ownership of at least fifty percent of the voting stock; liquidation or dissolution, or the common stock ceases to be listed on the market upon which it currently trades.

The holders of the Series C Preferred Stock are entitled to vote on any matter submitted to the stockholders of the Company for a vote. One share of Series C Preferred Stock carries the same voting rights as one share of common stock.

Redeemable equity security is to be classified as temporary equity if it is conditionally redeemable upon the occurrence of an event that is not solely within the control of the issuer. Upon the determination that such events are probable, the equity security would be classified as a liability. Given the Series C Preferred Stock contains a fundamental change provision, the security is considered conditionally redeemable. Therefore, the Company has classified the Series C Preferred Stock as temporary equity in the balance sheets on March 31, 2022, and December 31, 2021, until such time that events occur that indicate otherwise.

Warrants

There was no warrant activity during the three months ended March 31, 2022. The following table summarizes the Company’s warrants outstanding and exercisable on March 31, 2022, and December 31, 2021:

						Weighted
				Weighted		Average
				Average		Remaining		Aggregate
	Number of			Exercise		Life		Intrinsic
	Warrants			Price		In Years		Value
Outstanding and Exercisable at January 1, 2021		1,569,007		$	13.30		4.1	$	10,850,158
Issued		3,897,534		$	5.26		4.77		-
Exercised		(1,002,307	)	$	9.07		-		-
Cancelled		(168,854	)	$	38.32		-		-
Outstanding and Exercisable at December 31, 2021		4,295,380		$	6.02		4.59		-
Outstanding and Exercisable at March 31, 2022		4,295,380		$	6.02		4.52		-

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2022

Accounting Policies [Abstract]

USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

USE OF ESTIMATES IN THE FINANCIAL STATEMENTS

CASH

CASH

RESTRICTED CASH

RESTRICTED CASH

CONCENTRATIONS OF CREDIT RISK

CONCENTRATIONS OF CREDIT RISK

REVENUE RECOGNITION

REVENUE RECOGNITION

SALES TO DISTRIBUTORS AND RESELLERS

SALES TO DISTRIBUTORS AND RESELLERS

SHIPPING AND HANDLING

SHIPPING AND HANDLING

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE

INVENTORY

INVENTORY

LONG-LIVED ASSETS

LONG-LIVED ASSETS

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT

Equipment	5 years
Furniture and fixtures	3 to 5 years
Tooling and molds	2 to 3 years

GOODWILL

GOODWILL

OTHER INTANGIBLE ASSETS

OTHER INTANGIBLE ASSETS

The Company’s intangible assets are related to the acquisition of LogicMark and are included in other intangible assets in the Company’s balance sheet on March 31, 2022, and December 31, 2021.

CONVERTIBLE INSTRUMENTS

CONVERTIBLE INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

DERIVATIVE FINANCIAL INSTRUMENTS

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

NET LOSS PER SHARE

NET LOSS PER SHARE

RESEARCH AND DEVELOPMENT

RESEARCH AND DEVELOPMENT

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

Summary of Significant Accounting Policies (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Product Information [Line Items]
Restricted cash	$ 210,118		$ 210,131
Freight charges	191,662	$ 106,425
Allowance for doubtful accounts	7,014		5,411
Inventory finished goods	876,084		1,237,280
Prepaid expenses and other current assets	542,931		559,938
Amortization expense	194,106		187,845
Amortization expense estimated for 2022	567,709
Amortization expense estimated for 2023	761,815
Amortization expense estimated for 2024	761,815
Amortization expense estimated for 2025	761,815
Amortization expense estimated for 2026	618,790
Amortization expense estimated for 2027	$ 272,235
Stock options purchase (in Shares)	348,284	36,364
Warrant [Member]
Product Information [Line Items]
Warrants purchase (in Shares)	4,295,380	937,813
Logic Mark [Member] \| Patents [Member]
Product Information [Line Items]
Intangible assets of patents	$ 1,978,016		2,072,984
Other intangible assets, estimated useful lives	11 years
Logic Mark [Member] \| Trademarks [Member]
Product Information [Line Items]
Intangible assets trademarks	$ 899,599		915,619
Other intangible assets, estimated useful lives	20 years
Logic Mark [Member] \| Customer Relationships [Member]
Product Information [Line Items]
Intangible assets customer relationships	$ 1,404,926		$ 1,488,044
Other intangible assets, estimated useful lives	10 years

Stockholders' Equity (Details) - USD ($)					1 Months Ended	3 Months Ended
Stockholders' Equity (Details) - USD ($)	Oct. 15, 2021	Aug. 13, 2021	Feb. 02, 2021	May 01, 2017	Sep. 15, 2021	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021	Sep. 30, 2021
Stockholders' Equity (Details) [Line Items]
Reverse stock split, description	the Company announced that its shareholders had approved a reverse split of its common stock and Series C Preferred at a ratio of 1 for 10. As a result of the reverse split, every 10 pre-split shares of common stock outstanding and every 10 pre-split shares of Series C Preferred stock outstanding were automatically exchanged for one new share of each without any action on the part of the holders.
Common stock shares outstanding						9,593,378		9,163,039
Common stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Gross proceeds (in Dollars)					$ 12,500,000
Warrant term, description		On August 13, 2021, the Company entered into a securities purchase agreement with institutional accredited investors providing for an aggregate investment of $4,000,000 for the issuance by the Company of (i) 1,333,333 shares of Series F Convertible Preferred Stock, par value $0.0001 per share, of the Company (the Series F Preferred Stock) convertible into shares of common stock, par value $0.0001 per share, of the Company that is issuable upon conversion of shares of Series F Preferred Stock; (ii) warrants, with a term of five and a half years exercisable after February 16, 2022, to purchase an aggregate of up to 666,667 shares of Common Stock at an exercise price of $7.80 per share.
Investment (in Dollars)		$ 4,000,000
Preferred stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Voting rights, description						One share of Series C Preferred Stock carries the same voting rights as one share of common stock.
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares outstanding	88,300,000
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares outstanding	8,800,000
Series C Preferred Stock [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding						200		200
Preferred stock, par value (in Dollars per share)						$ 0.0001		$ 0.0001
Cumulative dividends rate				15.00%
Preferred stock dividends (in Dollars)						$ 75,000	$ 75,000
Series C Preferred Stock [Member] \| Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding	2,000
Series C Preferred Stock [Member] \| Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Preference stock shares outstanding	200
September 2021 Offering [Member]
Stockholders' Equity (Details) [Line Items]
Aggregate of sale, shares					2,788,750
Common stock, par value (in Dollars per share)					$ 0.0001
Aggregate of purchase shares					2,788,750
Exercise price per share (in Dollars per share)					$ 4.95
Additional shares of common stock					363,750
Warrant exercise price (in Dollars per share)	$ 3.956
August 2021 Offering [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, par value (in Dollars per share)		$ 0.0001
Shares issued		1,333,333
Preferred stock, par value (in Dollars per share)		$ 0.0001
Common stock, shares issued		666,667							656,604
Common stock exercise price per share (in Dollars per share)		$ 7.8
Preferred stock, shares issued									1,160,000
Warrants per share (in Dollars per share)	$ 4.95
July 2020 Offerings [Member]
Stockholders' Equity (Details) [Line Items]
Registered direct offering, description			(i) an aggregate of 1,476,016 shares of Series E preferred stock, convertible into up to 295,203 shares of common stock, (ii) common stock purchase warrants to purchase up to 100,000 shares of common stock at an exercise price of $12.30 per share, which were exercisable immediately and had a term of five years, and (iii) common stock purchase warrants to purchase up to 195,203 shares of common stock at an exercise price of $12.30 per share with a term of five and one-half years first exercisable nine months after issuance, for gross proceeds of $4,000,003, before deducting any offering expenses. The Company used the net proceeds from this offering for working capital and liability reduction purposes. In February 2021, 1,476,016 shares of Series E preferred stock were converted into 295,203 shares of common stock. Also in February 2021, the Company recorded a deemed dividend of $1,480,801 from the beneficial conversion feature associated with the issuance of the Series E convertible preferred stock and warrants.
January 2021 Warrant exchange [Member]
Stockholders' Equity (Details) [Line Items]
Common stock, shares issued						246,913
Common stock exercise price per share (in Dollars per share)						$ 15.25
Warrants						50,000
January 2021 Warrant exchange [Member] \| Warrant [Member]
Stockholders' Equity (Details) [Line Items]
Warrants						50,000

Stockholders' Equity (Details) - Schedule of warrants outstanding and exercisable - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Number of Warrants [Member]
Class of Warrant or Right [Line Items]
Number of Warrants, Outstanding	4,295,380	1,569,007
Number of Warrants, Issued		3,897,534
Number of Warrants, Exercised		(1,002,307)
Number of Warrants, Cancelled		(168,854)
Number of Warrants, Outstanding	4,295,380	4,295,380
Weighted Average Exercise Price [Member]
Class of Warrant or Right [Line Items]
Weighted Average Exercise Price, Outstanding	$ 6.02	$ 13.3
Weighted Average Exercise Price, Issued		5.26
Weighted Average Exercise Price, Exercised		9.07
Weighted Average Exercise Price, Cancelled		38.32
Weighted Average Exercise Price, Outstanding	$ 6.02	$ 6.02
Weighted Average Remaining Life In Years [Member]
Class of Warrant or Right [Line Items]
Weighted Average Remaining Life In Years, Outstanding		4 years 1 month 6 days
Weighted Average Remaining Life In Years, Issued		4 years 9 months 7 days
Weighted Average Remaining Life In Years, Exercised
Weighted Average Remaining Life In Years, Cancelled
Weighted Average Remaining Life In Years, Outstanding	4 years 6 months 7 days	4 years 7 months 2 days
Aggregate Intrinsic Value [Member]
Class of Warrant or Right [Line Items]
Aggregate Intrinsic Value, Outstanding		$ 10,850,158
Aggregate Intrinsic Value, Issued
Aggregate Intrinsic Value, Exercised
Aggregate Intrinsic Value, Cancelled
Aggregate Intrinsic Value, Outstanding

Stock Incentive Plans (Details) - USD ($)		1 Months Ended	3 Months Ended
Stock Incentive Plans (Details) - USD ($)	Jan. 04, 2013	Aug. 24, 2017	Mar. 31, 2022	Mar. 31, 2021
Stock Incentive Plans (Details) [Line Items]
Non-vested stock options			$ 1,087,407
Shares issued of stock options (in Shares)			237,500
Aggregate fair value stock options				$ 40,000
2017 Stock Incentive Plan [Member]
Stock Incentive Plans (Details) [Line Items]
Common shares outstanding, percentage		10.00%
Number of options vested (in Shares)			430,339
Stock fair value			$ 1,331,870	$ 80,456
Number of options vested (in Shares)				13,283
Accrued management and employee bonus expense			$ 244,463	$ 0
2017 Stock Incentive Plan [Member] \| Minimum [Member]
Stock Incentive Plans (Details) [Line Items]
Vesting period			30 years
2017 Stock Incentive Plan [Member] \| Maximum [Member]
Stock Incentive Plans (Details) [Line Items]
Vesting period			48 years
2013 Long-Term Stock Incentive Plan [Member]
Stock Incentive Plans (Details) [Line Items]
Common shares outstanding, percentage	10.00%
Stock options vesting term			4 years
Exercise price (in Dollars per share)			$ 3.36
Shares with strike (in Shares)			12,500
Strike price per share (in Dollars per share)			$ 2.2
Total expense			$ 325,336
Vested stock options shares (in Shares)			27,276
Directors exercise price (in Dollars per share)			$ 2.2
Aggregate fair value			$ 60,000
Stock options to purchase shares (in Shares)				2,837
Exercise price stock options (in Dollars per share)			$ 14.1

Summary of Significant Accounting Policies (Details) - Schedule of estimated useful life of property and equipment	3 Months Ended
	Mar. 31, 2022
Equipment [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Furniture and Fixtures [Member] \| Minimum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	3 years
Furniture and Fixtures [Member] \| Maximum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	5 years
Tooling and molds [Member] \| Minimum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	2 years
Tooling and molds [Member] \| Maximum [Member]
Public Utility, Property, Plant and Equipment [Line Items]
Estimated useful life	3 years

Accrued Expenses (Details) - Schedule of accrued expenses - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Schedule of accrued expenses [Abstract]
Salaries, payroll taxes and vacation	$ 79,199	$ 54,229
Merchant card fees	35,923	17,853
Professional fees	189,174	104,500
Management incentives	162,200	285,000
Lease liability	67,016	64,346
Dividends – Series C and F Preferred Stock	107,933	94,933
Other	124,868	228,424
Totals	$ 766,313	$ 849,285

Commitments and Contingencies (Details) - USD ($)	1 Months Ended	3 Months Ended
Commitments and Contingencies (Details) - USD ($)	Sep. 30, 2020	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Real estate lease term, description		The Company’s real estate lease, which is for office space and a fulfillment center, with a lease term of 5 years in August 2025. The Company also leases a copier with a lease term of 5 years, ending August 2023.
Monthly rent		$ 6,200
Increasing annual rent, percentage	3.00%
ROU asset value-added	$ 279,024
Operating lease cost		$ 24,558

Commitments and Contingencies (Details) - Schedule of future lease obligation	Mar. 31, 2022 USD ($)
Schedule of future lease obligation [Abstract]
2022 (excluding the three months ended March 31, 2022)	$ 70,239
2023	89,724
2024	80,000
2025	54,400
Total future minimum lease payments	294,363
Less imputed interest	(55,594)
Total present value of future minimum lease payments	$ 238,769

Commitments and Contingencies (Details) - Schedule of lease expense - Operating Expense [Member]	Mar. 31, 2022 USD ($)
Commitments and Contingencies (Details) - Schedule of lease expense [Line Items]
Operating lease right-of-use assets	$ 232,569
Other accrued expenses	67,016
Other long-term liabilities	171,754
Total	$ 238,770
Weighted Average Remaining Lease Term	4 years 3 months 18 days
Weighted Average Discount Rate	12.80%